Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Capital Work in Progress

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹2,739 Cr₹4,496 Cr₹2,938 Cr₹2,429 Cr₹1,622 Cr

What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?

The latest Capital Work in Progress ratio of AUROBINDO PHARMA is ₹2,739 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹2,739 Cr
Mar2023₹4,496 Cr
Mar2022₹2,938 Cr
Mar2021₹2,429 Cr
Mar2020₹1,622 Cr

How is Capital Work in Progress of AUROBINDO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹2,739 Cr
-39.08
Mar2023 ₹4,496 Cr
53.07
Mar2022 ₹2,938 Cr
20.94
Mar2021 ₹2,429 Cr
49.77
Mar2020 ₹1,622 Cr -

Compare Capital Work in Progress of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,667.3 Cr -4.2% -7.8% -12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.2%

-7.8%

-12.7%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses